🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The goal of this clinical trial is to compare two treatment regimes, namely...
Status
Recruiting
Location
Tata Memorial Centre
Start Date
2024-03-07
Trial ID
NCT06214572
We hypothesized that intra-arterial gemcitabine/oxaliplatin administered as...
Status
Recruiting
Location
Amiens University Hospital
Start Date
2018-06-11
Trial ID
NCT03364530
Treatments Being Tested
This is an open-label, phase 1/2, multiple-indication platform study to exp...
Status
Active Not Recruiting
Location
Nationales Centrum für Tumorerkrankungen Heidelberg
Start Date
2021-10-27
Trial ID
NCT07280377
The purpose of this clinical trial is to investigate whether the inclusion ...
Status
Not Yet Recruiting
Location
Zhongshan Hospital
Start Date
2024-07
Trial ID
NCT06502080
Biliary tract cancer (BTC), including cholangiocarcinoma and gallbladder ca...
Status
Recruiting
Location
Peking University Cancer Hospital
Start Date
2026-03-31
Trial ID
NCT07466238
This study will be separated into 3 distinct phases designated as the Phase...
Status
Completed
Location
Banner MD Anderson Cancer Center
Start Date
2015-04-21
Trial ID
NCT02348216
A phase II trial evaluating intra-hepatic chemotherapy with oxaliplatin eve...
Status
Completed
Location
Herlev Hospital
Start Date
2011-02-02
Trial ID
NCT01247337
Besides liver transplantation, the curative treatment of primary hepatic ca...
Status
Terminated
Location
Urc La Pitie Salpetriere,
Start Date
2007-06
Trial ID
NCT00470340
Treatments Being Tested
This study will compare the safety and effects of HAI floxuridine and dexam...
Status
Recruiting
Location
National Heart, Lung, and Blood Institute (NIH) (Data Collection Only)
Start Date
2021-05-07
Trial ID
NCT04891289
Treatments Being Tested
The study is a first-in-human (FIH), open-label, multi-center phase 1/2 stu...
Status
Recruiting
Location
MD Anderson Cancer Center
Start Date
2024-04-29
Trial ID
NCT06385925